Reduced ion therapeutic instrument for improving microcirculation of human body

Abstract

The present application relates to the technical field of reduction ion therapeutic instrument, and particularly relates to a reduction ion therapeutic instrument for improving microcirculation of human body, which comprises: a control panel, which is a main control end of the system, is used for issuing execution commands and receiving user click operations; an acquisition module, which is used for acquiring body parameter information of a user of the reduction ion therapeutic instrument; a monitoring module, which is used for monitoring and acquiring heart rate and blood pressure of the user of the reduction ion therapeutic instrument in real time; and an adjusting module, which is used for adjusting electrostatic magnetic field intensity value of the reduction ion therapeutic instrument each time. The present application controls the reduction ion therapeutic instrument in an intelligent manner by deploying the system in the reduction ion therapeutic instrument. In the system running process, whether the user's body state is suitable for using the reduction ion therapeutic instrument is determined in priority through the user's body parameter information, so as to ensure the use safety of the reduction ion therapeutic instrument. Furthermore, whether the user's body state is stable in the process of using the reduction ion therapeutic instrument is further collected in real time by monitoring the user's heart rate and blood pressure.

Description

Technical Field

[0001] This invention relates to the field of reducing ion therapy technology, specifically to a reducing ion therapy device for improving human microcirculation. Background Technology

[0002] The reducing ion therapy device is a type of physical therapy instrument, also known as a high-potential therapy device or an electrostatic therapy device. It places the human body in a safe electrostatic field, providing stimulation with a high-voltage alternating current potential of several thousand volts. This electrical energy activates cells, improves sodium-calcium channels in cell membranes, and moderately adjusts the distribution of mineral ions inside and outside the cells. While regulating the autonomic nervous system and microcirculation system, it reduces blood viscosity, placing the blood in a healthy, slightly alkaline state. This comprehensive approach aims to treat various chronic diseases, enhance immunity, improve physical condition, and prevent disease—making it a comprehensive health care and physiotherapy instrument.

[0003] Currently, the use of reducing ion therapy devices only involves controlling the intensity of the electrostatic magnetic field emitted by the device through user settings to maintain the user's body. The blood circulation between the microarteries and microveins in the user's body cannot be captured by the reducing ion therapy device, so the reducing ion therapy device cannot adjust the intensity of the emitted electrostatic magnetic field on its own. The therapeutic effect obtained by the user using the reducing ion therapy device is limited by the user's settings when using the reducing ion therapy device, and it is impossible to find the electrostatic magnetic field intensity that is most suitable for the user. Summary of the Invention

[0004] Technical problems to be solved

[0005] In view of the above-mentioned shortcomings of the existing technology, the present invention provides a reducing ion therapy device for improving human microcirculation, which solves the technical problems mentioned in the background art.

[0006] Technical solution

[0007] To achieve the above objectives, the present invention provides the following technical solution:

[0008] A reducing ion therapy device for improving human microcirculation includes:

[0009] The control panel is the main control terminal of the system, used to issue execution commands and receive user click operations;

[0010] The data acquisition module is used to collect the body parameter information of the user of the ion therapy device.

[0011] The monitoring module is used to monitor and obtain the heart rate and blood pressure of the user of the reducing ion therapy device in real time;

[0012] The adjustment module is used to adjust the intensity of the electrostatic magnetic field emitted by the reducing ion therapy device each time.

[0013] The identification module is used to identify the line undulation changes in the line graphs constructed in the building units;

[0014] The tracing module is used to obtain the line segment with the smallest line undulation change value in the line graph identified by the recognition module or the line graph line segment selected by the user through the selection unit, and to trace the line segment back to the electrostatic magnetic field strength value in the set electrostatic magnetic field strength threshold set in the setting unit corresponding to the line segment.

[0015] The modification module is used to obtain the electrostatic magnetic field strength value of the traceability module's traceability result, and to set the electrostatic magnetic field strength value emitted by the reduction ion therapy device during operation with reference to the electrostatic magnetic field strength value.

[0016] Furthermore, the acquisition module has sub-modules at its lower level, including:

[0017] The editing unit is used to set user body parameter information tags for users to select;

[0018] The determination unit is used to determine whether the user meets the conditions for using the reducing ion therapy device.

[0019] The user's body parameter information tags set in the editing unit include safety tags and threat tags. Safety tags are manually edited and entered by the user. Threat tags include: carrying a high fever disease, having a bleeding disease, heart or kidney failure, lung failure, recovering from heart surgery, tumors, infectious diseases, having silicone or metal inside the body, and during pregnancy.

[0020] Furthermore, the determination unit captures the body parameter information tags selected by the user in the editing unit through the acquisition module in real time. After identifying any threat tag, the determination unit triggers a determination result of no and simultaneously feeds back the determination result to the control panel.

[0021] Furthermore, the monitoring module includes sub-modules, including:

[0022] The recording unit is used to record the user's heart rate and blood pressure as monitored in real time by the monitoring module.

[0023] The recording unit is configured with a recording period, and the recording unit selects the user's heart rate and blood pressure according to the recording period for recording and storage.

[0024] Furthermore, the adjustment module has sub-modules at its lower level, including:

[0025] The setting unit is used to set the threshold value of the electrostatic magnetic field intensity emitted by the reducing ion therapy device and the adjustment module adjusts the value of the electrostatic magnetic field intensity emitted by the reducing ion therapy device each time.

[0026] The marking unit is used to configure the current electrostatic magnetic field strength value of the reducing ion therapy device to be marked in the user's heart rate and blood pressure data recorded in the recording unit;

[0027] The user obtains and records the user's heart rate and blood pressure after processing by the labeling unit in the recording unit, and constructs a linear graph with reference to the user's heart rate, blood pressure and the corresponding labeled electrostatic magnetic field strength value of the reduced ion therapy instrument.

[0028] Furthermore, during the process of generating the line graph by the building unit, feedback is simultaneously sent to the control panel, which displays the graph for the user of the reducing ion therapy device to read.

[0029] Furthermore, during operation, the recognition module captures the turning points of the line graph and calculates the line undulation values ​​based on these turning points. The recognition module has sub-modules at its lower level, including:

[0030] The selection unit allows users to choose specific lines within a line graph.

[0031] Furthermore, when the recognition module is running, a pop-up window is simultaneously triggered and displayed on the control panel. The user can select the recognition module or select a unit through the pop-up window to run it.

[0032] When the system reaches the recognition module, a selection period is set. After the selection period ends, the system will run the recognition module by default.

[0033] Furthermore, when the reduction ion therapy device finishes running, the modification module will simultaneously trigger a pop-up prompt for the user to confirm whether to run the device according to the electrostatic magnetic field strength value modified by the modification module the next time the reduction ion therapy device is run.

[0034] Furthermore, the control panel is electrically connected to a data acquisition module via a medium. The data acquisition module is further electrically connected to an editing unit and a judgment unit via a medium. The data acquisition module is also electrically connected to a monitoring module via a medium. The monitoring module is electrically connected to a recording unit via a medium. The monitoring module is electrically connected to an adjustment module via a medium. The adjustment module is electrically connected to a setting unit, a marking unit, and a construction unit via a medium. The construction unit is electrically connected to the control panel via a medium. The adjustment module is electrically connected to an identification module via a medium. The identification module is electrically connected to a selection unit via a medium. The identification module is electrically connected to a traceability module and a modification module via a medium.

[0035] Beneficial effects

[0036] Compared with known public technologies, the technical solution provided by this invention has the following beneficial effects:

[0037] 1. This invention provides a reducing ion therapy device for improving human microcirculation. The device is intelligently controlled by deploying a system within it. During operation, the system prioritizes determining whether the user's physical condition is suitable for using the device based on their body parameters, thus ensuring safe use. Furthermore, by monitoring the user's heart rate and blood pressure, the system collects real-time data on the stability of the user's physical condition during use, providing data support for subsequent system operation. This allows the next use of the reducing ion therapy device to be tailored to the user's optimal condition, thereby improving microcirculation.

[0038] 2. In this invention, the system collects and records the heart rate and blood pressure data of the user during the use of the reducing ion therapy device, and simultaneously configures the electrostatic magnetic field strength value of the reducing ion therapy device under real-time heart rate and blood pressure conditions. This further constructs a line graph of various parameters for the user to read and the system to analyze. This helps the reducing ion therapy device to find the most suitable working state for the user more quickly, thereby improving the positive effects of the reducing ion therapy device on the user's body. Attached Figure Description

[0039] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the accompanying drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are merely some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without any creative effort.

[0040] Figure 1 A schematic diagram illustrating the external structure of a reducing ion therapy device for improving human microcirculation;

[0041] Figure 2 This is a schematic diagram of the internal system structure of the reducing ion therapy device in this invention;

[0042] The labels in the diagram represent: 1. Control panel; 2. Acquisition module; 21. Editing unit; 22. Judgment unit; 3. Monitoring module; 31. Recording unit; 4. Adjustment module; 41. Setting unit; 42. Marking unit; 43. Construction unit; 5. Identification module; 51. Selection unit; 6. Traceability module; 7. Modification module. Detailed Implementation

[0043] To make the objectives, technical solutions, and advantages of the embodiments of the present invention clearer, the technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some, not all, of the embodiments of the present invention. All other embodiments obtained by those skilled in the art based on the embodiments of the present invention without creative effort are within the scope of protection of the present invention.

[0044] The present invention will be further described below with reference to embodiments.

[0045] Example 1

[0046] This embodiment describes a reducing ion therapy device for improving human microcirculation, such as... Figure 1 As shown, it includes:

[0047] Control Panel 1 is the main control terminal of the system, used to issue execution commands and receive user click operations;

[0048] Data acquisition module 2 is used to collect body parameter information of the user of the reducing ion therapy device;

[0049] Monitoring module 3 is used to monitor and acquire the heart rate and blood pressure of the user of the reducing ion therapy device in real time;

[0050] Adjustment module 4 is used to adjust the intensity of the electrostatic magnetic field emitted by the reducing ion therapy device each time;

[0051] The identification module 5 is used to identify the line undulation change values ​​of the line graph constructed in the construction unit 43;

[0052] The tracing module 6 is used to obtain the line segment with the smallest line undulation change value in the line graph identified by the identification module 5 or the line graph line segment selected by the user through the selection unit 51, and to trace the line segment to the electrostatic magnetic field strength value in the set electrostatic magnetic field strength threshold set in the setting unit 41 corresponding to the line segment.

[0053] Modify module 7 to obtain the electrostatic magnetic field strength value of the traceability result from module 6, and set the electrostatic magnetic field strength value emitted by the reduction ion therapy device during operation with reference to the electrostatic magnetic field strength value.

[0054] In this embodiment, the control panel 1 controls the operation of the acquisition module 2 to acquire the body parameter information of the user of the reducing ion therapy device. The monitoring module 3 then monitors and obtains the user's heart rate and blood pressure in real time. Simultaneously, the adjustment module 4 adjusts the electrostatic magnetic field strength value emitted by the reducing ion therapy device each time. The identification module 5 runs afterward to identify the line fluctuation value of the line graph constructed in the construction unit 43. Finally, the tracing module 6 obtains the line segment with the smallest line fluctuation value in the line graph identified by the identification module 5 or the line graph line segment selected by the user through the selection unit 51. The tracing module 6 refers to the obtained line segment and traces the electrostatic magnetic field strength value in the set electrostatic magnetic field strength threshold set in the setting unit 41 corresponding to the obtained line segment. The modification module 7 runs to obtain the electrostatic magnetic field strength value of the tracing module 6, and sets the electrostatic magnetic field strength value emitted by the reducing ion therapy device when it is running with reference to the electrostatic magnetic field strength value.

[0055] Example 2

[0056] At the implementation level, based on Example 1, this example refers to... Figure 1 The following is a further detailed description of a reducing ion therapy device for improving human microcirculation in Example 1:

[0057] The data acquisition module 2 has sub-modules, including:

[0058] Editing unit 21 is used to set user body parameter information labels for users to select;

[0059] Judgment unit 22 is used to determine whether the user meets the conditions for using the reducing ion therapy device;

[0060] The user's body parameter information tags set in the editing unit 21 include safety tags and threat tags. Safety tags are manually edited and entered by the user. Threat tags include: carrying a high fever disease, having a bleeding disease, heart or kidney failure, lung failure, recovering from heart surgery, tumors, infectious diseases, having silicone or metal inside the body, and during pregnancy.

[0061] Preferably, the judgment unit 22 performs real-time capture of the body parameter information tags selected by the user in the editing unit 21 through the acquisition module 2. After identifying any threat tag, the judgment unit 22 triggers a judgment result of no and simultaneously feeds back the judgment result to the control panel 1.

[0062] This setting allows the system to analyze the user's condition before the ion therapy device is used, thereby ensuring the user's safety when using the device.

[0063] Preferably, the monitoring module 3 includes a sub-module, including:

[0064] Recording unit 31 is used to record the user's heart rate and blood pressure as monitored in real time by monitoring module 3;

[0065] The recording unit 31 is configured with a recording cycle. The recording unit 31 operates by selecting the user's heart rate and blood pressure according to the recording cycle and recording and storing them.

[0066] This setting allows the user's heart rate and blood pressure data monitored by monitoring module 3 to be recorded, so that the lower-level modules of monitoring module 3 can obtain sufficient data support when running.

[0067] Preferably, the adjustment module 4 has sub-modules at its lower level, including:

[0068] Setting unit 41 is used to set the threshold value of the electrostatic magnetic field strength emitted by the reducing ion therapy device and to adjust the value of the electrostatic magnetic field strength emitted by the reducing ion therapy device each time by adjustment module 4.

[0069] The marking unit 42 is used to mark the current electrostatic magnetic field strength value of the reducing ion therapy device in the user's heart rate and blood pressure data recorded in the recording unit 31;

[0070] In the construction unit 43, the user obtains the user's heart rate and blood pressure after processing by the marking unit 42 in the recording unit 31, and constructs a linear graph with reference to the user's heart rate, blood pressure and the corresponding marked electrostatic magnetic field strength value of the reduced ion therapy instrument.

[0071] By setting the sub-modules in the adjustment module 4, the electrostatic magnetic field strength value generated during the operation of the reducing ion therapy device can be configured with the real-time heart rate and blood pressure data of the user detected by the monitoring module 3. This data can then be used to construct a line graph, which helps the user understand the device, improves the user experience of the reducing ion therapy device, and helps find the optimal operating state of the reducing ion therapy device for the user to use.

[0072] Preferably, during the process of generating the line graph by the construction unit 43, feedback is simultaneously sent to the control panel 1, and the graph is displayed on the control panel 1 for the user of the reducing ion therapy device to read.

[0073] Example 3

[0074] At the implementation level, based on Example 1, this example refers to... Figure 1 The following is a further detailed description of a reducing ion therapy device for improving human microcirculation in Example 1:

[0075] Preferably, when the recognition module 5 is running, it captures the turning points of the line graph and calculates the line undulation value based on the turning points. The recognition module 5 has sub-modules, including:

[0076] Selection unit 51 is used for users to select a portion of the lines in the line graph.

[0077] Preferably, when the recognition module 5 is running, a pop-up window is simultaneously triggered and displayed on the control panel 1. The user can select the recognition module 5 or select unit 51 through the pop-up window to run it.

[0078] When the system reaches the recognition module 5, a selection period is set. After the selection period ends, the system will run the recognition module 5 by default.

[0079] Preferably, when the reduction ion therapy device finishes running, the modification module 7 will simultaneously trigger a pop-up prompt for the user to confirm whether to run according to the electrostatic magnetic field strength value modified by the modification module 7 during the next run of the reduction ion therapy device.

[0080] This setting provides an alternative operating logic for the system, allowing it to run according to the user's chosen settings, thus enabling the reducing ion therapy device to have more user-friendly settings when operating with this system.

[0081] Preferably, the control panel 1 is electrically connected to the acquisition module 2 via a medium. The acquisition module 2 is electrically connected to the editing unit 21 and the judgment unit 22 via a medium. The acquisition module 2 is electrically connected to the monitoring module 3 via a medium. The monitoring module 3 is electrically connected to the recording unit 31 via a medium. The monitoring module 3 is electrically connected to the adjustment module 4 via a medium. The adjustment module 4 is electrically connected to the setting unit 41, the marking unit 42 and the construction unit 43 via a medium. The construction unit 43 is electrically connected to the control panel 1 via a medium. The adjustment module 4 is electrically connected to the identification module 5 via a medium. The identification module 5 is electrically connected to the selection unit 51 via a medium. The identification module 5 is electrically connected to the traceability module 6 and the modification module 7 via a medium.

[0082] The above embodiments are only used to illustrate the technical solutions of the present invention, and are not intended to limit it. Although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art should understand that modifications can still be made to the technical solutions described in the foregoing embodiments, or equivalent substitutions can be made to some of the technical features. Such modifications or substitutions will not cause the essence of the corresponding technical solutions to deviate from the spirit and scope of the technical solutions of the embodiments of the present invention.

Claims

1. A reducing ion therapy device for improving human microcirculation, characterized in that, include: The control panel (1) is the main control terminal of the system, used to issue execution commands and receive user click operations; The acquisition module (2) is used to collect the body parameter information of the user of the reducing ion therapy device; The monitoring module (3) is used to monitor and acquire the heart rate and blood pressure of the user of the reducing ion therapy device in real time. The monitoring module (3) is equipped with a sub-module, including a recording unit (31), which is used to record the user's heart rate and blood pressure monitored by the monitoring module (3) in real time. The adjustment module (4) is used to adjust the intensity of the electrostatic magnetic field emitted by the reducing ion therapy device each time. The adjustment module (4) has sub-modules at its lower level, including: The setting unit (41) is used to set the threshold value of the electrostatic magnetic field intensity emitted by the reducing ion therapy device and the adjustment module (4) adjusts the value of the electrostatic magnetic field intensity emitted by the reducing ion therapy device each time. The marking unit (42) is used to mark the current electrostatic magnetic field strength value of the reducing ion therapy device in the user's heart rate and blood pressure data recorded in the recording unit (31); The construction unit (43) obtains the user's heart rate and blood pressure after processing by the marking unit (42) in the recording unit (31), and constructs a line graph representing the relationship between the user's heart rate, blood pressure and the electrostatic magnetic field intensity value emitted by the corresponding marked reduction ion therapy device by referring to the user's heart rate, blood pressure and the corresponding marked reduction ion therapy device. The identification module (5) is used to identify the line undulation change values ​​of the line graph constructed in the construction unit (43); The tracing module (6) is used to obtain the line segment with the smallest line fluctuation change value in the line graph identified by the identification module (5) or the line graph line segment selected by the user through the selection unit (51), and to obtain the electrostatic magnetic field strength value in the electrostatic magnetic field strength threshold set in the setting unit (41) corresponding to the line segment. Modify module (7) to obtain the electrostatic magnetic field strength value in the traceability result of traceability module (6), and set the electrostatic magnetic field strength value emitted by the reduction ion therapy device when it is running with reference to the electrostatic magnetic field strength value in the traceability result.

2. The reducing ion therapy device for improving human microcirculation according to claim 1, characterized in that, The acquisition module (2) has sub-modules at its lower level, including: Editing unit (21) is used to set user body parameter information labels for users to select; The determination unit (22) is used to determine whether the user meets the conditions for using the reducing ion therapy device; Among them, the user body parameter information tags set in the editing unit (21) include safety tags and threat tags. The safety tags are manually edited and input by the user. Threat tags include: carrying a high fever disease, having a bleeding disease, heart failure, kidney failure, lung failure, heart surgery recovery period, tumor, infectious disease, having silicone and metal inside the body, and during pregnancy.

3. The reducing ion therapy device for improving human microcirculation according to claim 2, characterized in that, The determination unit (22) performs real-time capture of the body parameter information tags selected by the user in the editing unit (21) through the acquisition module (2). After identifying any threat tag, the determination unit (22) triggers a determination result of no and simultaneously feeds back the determination result to the control panel (1).

4. The reducing ion therapy device for improving human microcirculation according to claim 1, characterized in that, The recording unit (31) is set with a recording cycle. The recording unit (31) operates to select the user's heart rate and blood pressure according to the recording cycle for recording and storage.

5. A reducing ion therapy device for improving human microcirculation according to claim 1, characterized in that, The construction unit (43) synchronously feeds back to the control panel (1) during the process of generating the line graph, and displays it on the control panel (1) for the user of the reducing ion therapy device to read.

6. A reducing ion therapy device for improving human microcirculation according to claim 1, characterized in that, When the recognition module (5) is running, it captures the turning points of the line graph and calculates the line undulation value with reference to the turning points. The recognition module (5) has sub-modules at the lower level, including: Selection unit (51) is used for users to select a portion of the lines in the line graph.

7. A reducing ion therapy device for improving human microcirculation according to claim 6, characterized in that, When the identification module (5) is running, a pop-up window is simultaneously triggered and displayed on the control panel (1). The user can select either the identification module (5) or the selection unit (51) to run through the pop-up window. When the system runs to the identification module (5), a selection period is set. After the selection period ends, the system defaults to running the identification module (5).

8. A reducing ion therapy device for improving human microcirculation according to claim 1, characterized in that, When the reduction ion therapy device finishes running, the modification module (7) will trigger a pop-up prompt for the user to confirm whether to run according to the electrostatic magnetic field strength value modified by the modification module (7) in the next run of the reduction ion therapy device.

9. A reducing ion therapy device for improving human microcirculation according to claim 1, characterized in that, The control panel (1) is electrically connected to a data acquisition module (2) via a medium. The data acquisition module (2) is electrically connected to an editing unit (21) and a judgment unit (22) via a medium. The data acquisition module (2) is electrically connected to a monitoring module (3) via a medium. The monitoring module (3) is electrically connected to a recording unit (31) via a medium. The monitoring module (3) is electrically connected to an adjustment module (4) via a medium. The adjustment module (4) is electrically connected to a setting unit (41), a marking unit (42), and a construction unit (43) via a medium. The construction unit (43) is electrically connected to the control panel (1) via a medium. The adjustment module (4) is electrically connected to an identification module (5) via a medium. The identification module (5) is electrically connected to a selection unit (51) via a medium. The identification module (5) is electrically connected to a traceability module (6) and a modification module (7) via a medium.

Images